Cargando...
miR-520g and miR-520h overcome bortezomib resistance in multiple myeloma via suppressing APE1
Background: Nowadays, microRNAs (miRNAs) attract much attention in regulating anticancer drug resistance in cancers including multiple myeloma (MM). Bortezomib is the first-line choice in MM treatment, and bortezomib resistance caused by aberrant DNA repair leads to the recurrence and therapeutic fa...
Gardado en:
| Publicado en: | Cell Cycle |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Taylor & Francis
2019
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6619958/ https://ncbi.nlm.nih.gov/pubmed/31204563 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384101.2019.1632138 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|